SOURCE: EntreMetrix Corp.

July 11, 2006 09:00 ET

EntreMetrix Portfolio Company PreVantix Launches Its First Product

IRVINE, CA -- (MARKET WIRE) -- July 11, 2006 -- EntreMetrix, Inc. (OTCBB: ERMX) today announced that PreVantix has launched the sale and distribution of its first product, Prevenox™. Prevenox (L-Ergothioneine USP) is a unique, naturally occurring antioxidant found in most plants and animals. It has been shown that Prevenox plays a dual role in both energy regulation and in protecting cells from oxidative damage. Oxidative Stress has been proven to be a contributing factor to multiple diseases and to accelerate aging.

In an expanded introduction of PreVantix, Dave Rose, PreVantix's CEO, stated, "Patents have been issued describing Prevenox (L-Ergothioneine) as the only antioxidant that chelates, or combines with, heavy metals, while protecting cells (mitochondria) from damage. The avidity by which dietary ergothioneine is assimilated by tissues, the specific and significant effects it has on cellular processes, and the degree to which it is conserved by cells suggest an important physiological role for this super anti-oxidant."

PreVantix, an EntreMetrix portfolio company, focuses on the commercialization of patented pharmaceutical science and technologies which address disease management and preventive medicine applications.

EntreMetrix plans to develop a number of portfolio investment scenarios in its quest to increase the Company's net asset value. The Company intends to accelerate its Business Development platform by using its expertise in capital formation, strategic growth and public market entry to the benefit of its eligible portfolio companies. EntreMetrix's expertise provides unique advantages for its eligible portfolio companies, including the possibility of creating a liquid market for the companies' securities. The Company's plan includes equity distribution of each portfolio company to EntreMetrix shareholders of record at the time of a public market entry of the Company's portfolio investments.

About EntreMetrix: Based in Irvine, California, EntreMetrix is a Business Development Company, regulated under the Investment Company Act of 1940, and a provider of essential structural and financial support services to small business clients throughout the United States. The Company's structural support services create value for clients by providing expertise in the areas of employee and financial management -- eliminating the need for clients to manage non-core functions. For many clients, the EntreMetrix relationship results in access to structural and financial resources needed to sharpen business focus and accelerate growth. For more information on EntreMetrix, Inc., visit the company's Web site at or contact Scott W. Absher (888) 798-9100. The Company's corporate offices are located in Southern California at 18101 Von Karman Avenue, Suite 330, Irvine, California 92612.

Safe Harbor Statement: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "ACT"). Statements in this release that relate to the Company's plans and strategies, as well as management's expectations about new and existing products and services, acquisitions and opportunities, market growth, demand for acceptance of new and existing products and services are forward-looking statements. In particular, when used in the preceding discussion, the words "estimated," "believe," "optimistic," "expect," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the ACT and are subject to risks and uncertainties, and actual results could differ materially from those expressed in forward-looking statements. Such risks and uncertainties include, but are not limited to, unfavorable market conditions, increased competition, limited working capital, and failure to implement business strategies, actions by regulatory agencies, and other risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors. The Company undertakes no obligations to publicly update or revise such statements. For more details, please refer to the Company's Securities and Exchange Commission filings.

Contact Information